The BMJ: Depo-Provera: WHO set to review guidance on use by women at high HIV risk
“A World Health Organization guideline development group will convene next week (29-31 July) to review recommendations for the use of contraceptive methods by women at high risk of contracting HIV. The group will review the status of the three monthly injectable contraceptive Depo-Provera, using new evidence from a randomized clinical trial published in The Lancet last month…” (Iacobucci, 7/25).